NMYSF

NamSys earns a Neutral rating with a 54.2 composite score and conviction of two out of five. Fundamentals provide the principal support at 72, driven by exceptional gross- and operating-margin subscores, positive EBITDA, profitable net income, and a stable financial condition. Regulatory contributes a moderate 58, reflecting a favorable Canadian jurisdiction posture and no enforcement hits, offset by weak filing cadence. Market contributes only 40 because no institutional quote is available, while editorial ranks lowest at 30 following no newsroom or brief activity. The resulting profile combines strong operating economics with limited market visibility and sparse information flow.

Licensed fundamentals data show year-over-year revenue growth of 6.1%, indicating expansion but not a high-growth trajectory. Gross margin approaches 62.9%, while operating margin stands near 39.3%; both profitability measures earn maximum subscores and form the core of the investment case. EBITDA totals roughly $3.31 million, and net income reaches approximately $2.54 million, reinforcing the stable financial-condition assessment. The company’s market capitalization is about $20.14 million, a scale that produces a low market-cap tier subscore despite robust profitability. Primary regulatory filings show no dated latest filing, no regulatory events across the past 90 or 180 days, and no enforcement hits. That combination supports the enforcement assessment but leaves cadence as the clear regulatory weakness. Institutional pricing feeds provide no current quote, and CIN newsroom coverage records no recent newsroom or brief hits.

The forward catalyst rests on the 72-point fundamentals pillar, particularly the unusually strong margin structure and positive earnings base. Continued revenue expansion accompanied by gross margin near the current level and operating margin around the present range would validate the company’s capacity to convert modest growth into substantial profitability. A timely primary regulatory filing could improve transparency, while renewed institutional pricing availability and CIN newsroom coverage could broaden visibility; neither carries the same weight as operating execution. The single most important signal to watch is whether the next reported period sustains the operating margin while extending year-over-year revenue growth.